Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SLC39A13 | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-08 |
mRNA | BUB1B | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
mRNA | LIN9 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
mRNA | B4GALT7 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-08 |
mRNA | PEA15 | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-08 |
mRNA | PTBP1 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
mRNA | RCC2 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
mRNA | PDS5B | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
mRNA | RP11-106M3.2 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-08 |
mRNA | ASF1A | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |